Jon Wigginton
Board Member
Cullinan Therapeutics, Inc. (CGEM)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Macrogenics Inc (MGNX)
Proxy statement
Start not stated–2020-03-27
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Macrogenics Inc
MGNX
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Cullinan Therapeutics, Inc. (CGEM) | Chief Medical Officer | $321,122 | $4,544,022 |
| 2019 | Macrogenics Inc (MGNX) | Senior Vice President, Clinical Development and Chief Medical Officer | $453,454 | $1,942,251 |
| 2018 | Macrogenics Inc (MGNX) | Senior Vice President, Clinical Development and Chief Medical Officer | $460,000 | $1,976,107 |
| 2017 | Macrogenics Inc (MGNX) | Senior Vice President, Clinical Development and Chief Medical Officer | $445,050 | $1,516,458 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.